<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="782" width="593">
	<fontspec id="font0" size="9" family="AdvC2866" color="#231f20"/>
	<fontspec id="font1" size="9" family="AdvC2867" color="#231f20"/>
	<fontspec id="font2" size="9" family="AdvP4C4E74" color="#231f20"/>
	<fontspec id="font3" size="10" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font4" size="9" family="AdvPS586B" color="#231f20"/>
	<fontspec id="font5" size="10" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font6" size="8" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font7" size="8" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font8" size="9" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font9" size="9" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font10" size="8" family="AdvPSMy-BI" color="#231f20"/>
	<fontspec id="font11" size="8" family="AdvP4C4E74" color="#231f20"/>
	<fontspec id="font12" size="7" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font13" size="7" family="AdvPS586B" color="#231f20"/>
	<fontspec id="font14" size="5" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font15" size="5" family="AdvPSMy-RI" color="#231f20"/>
	<fontspec id="font16" size="5" family="AdvP4C4E74" color="#231f20"/>
<text top="328" left="54" width="234" height="8" font="font0" id="p1_t1" reading_order_no="8" segment_no="8" tag_type="text">High triglycerides and low HDL-C are two of the criteria</text>
<text top="339" left="45" width="243" height="8" font="font0" id="p1_t2" reading_order_no="9" segment_no="8" tag_type="text">used to diagnose metabolic syndrome. We examined the</text>
<text top="350" left="45" width="243" height="8" font="font0" id="p1_t3" reading_order_no="10" segment_no="8" tag_type="text">correlation between EL mass and HDL-C concentrations in</text>
<text top="361" left="45" width="243" height="8" font="font0" id="p1_t4" reading_order_no="11" segment_no="8" tag_type="text">participants with central obesity as deﬁned by NCEP ATPIII</text>
<text top="372" left="45" width="243" height="8" font="font0" id="p1_t5" reading_order_no="12" segment_no="8" tag_type="text">metabolic syndrome waist circumference criteria (greater</text>
<text top="383" left="45" width="243" height="8" font="font0" id="p1_t6" reading_order_no="13" segment_no="8" tag_type="text">than 35 inches in women and greater than 40 inches in men).</text>
<text top="394" left="45" width="243" height="8" font="font0" id="p1_t7" reading_order_no="14" segment_no="8" tag_type="text">There were stronger negative correlations between post-</text>
<text top="404" left="45" width="243" height="9" font="font0" id="p1_t8" reading_order_no="15" segment_no="8" tag_type="text">heparin EL mass in both men and women, r ¼ 0.25, p ¼ 0.03</text>
<text top="415" left="45" width="144" height="9" font="font0" id="p1_t9" reading_order_no="16" segment_no="8" tag_type="text">and r ¼ 0.31, p ¼ 0.03, respectively.</text>
<text top="427" left="54" width="234" height="8" font="font0" id="p1_t10" reading_order_no="17" segment_no="9" tag_type="text">Since there were signiﬁcant correlations between EL mass</text>
<text top="438" left="45" width="243" height="8" font="font0" id="p1_t11" reading_order_no="18" segment_no="9" tag_type="text">and each of the metabolic syndrome parameters, we</text>
<text top="450" left="45" width="243" height="8" font="font0" id="p1_t12" reading_order_no="19" segment_no="9" tag_type="text">examined differences in median post-heparin EL mass with</text>
<text top="461" left="45" width="243" height="8" font="font0" id="p1_t13" reading_order_no="20" segment_no="9" tag_type="text">increasing numbers of metabolic syndrome factors present</text>
<text top="472" left="45" width="243" height="8" font="font0" id="p1_t14" reading_order_no="21" segment_no="9" tag_type="text">(Figure 1). There was an additive effect of increasing numbers</text>
<text top="483" left="45" width="243" height="8" font="font0" id="p1_t15" reading_order_no="22" segment_no="9" tag_type="text">of metabolic syndrome factors, with median EL mass</text>
<text top="494" left="45" width="243" height="8" font="font0" id="p1_t16" reading_order_no="23" segment_no="9" tag_type="text">increasing from 328 ng/ml in individuals with no factors to</text>
<text top="505" left="45" width="215" height="8" font="font0" id="p1_t17" reading_order_no="24" segment_no="9" tag_type="text">642 ng/ml in participants with all ﬁve factors present.</text>
<text top="523" left="45" width="232" height="9" font="font3" id="p1_t18" reading_order_no="25" segment_no="11" tag_type="title">Association of EL Concentrations with Coronary Artery</text>
<text top="535" left="45" width="51" height="9" font="font3" id="p1_t19" reading_order_no="26" segment_no="11" tag_type="title">Calcification</text>
<text top="547" left="54" width="234" height="8" font="font0" id="p1_t20" reading_order_no="27" segment_no="13" tag_type="text">CAC scores increased across quartiles of both pre- and</text>
<text top="558" left="45" width="243" height="8" font="font0" id="p1_t21" reading_order_no="28" segment_no="13" tag_type="text">post-heparin EL concentrations in men (for trend, p , 0.001</text>
<text top="319" left="306" width="243" height="8" font="font0" id="p1_t22" reading_order_no="37" segment_no="7" tag_type="text">for both) and women (for trend, p , 0.001 for both) (Figure</text>
<text top="331" left="306" width="243" height="8" font="font0" id="p1_t23" reading_order_no="38" segment_no="7" tag_type="text">2). Using multivariable ordinal regression analyses of the</text>
<text top="342" left="306" width="243" height="8" font="font0" id="p1_t24" reading_order_no="39" segment_no="7" tag_type="text">entire cohort, plasma concentrations of both pre- and post-</text>
<text top="354" left="306" width="243" height="8" font="font0" id="p1_t25" reading_order_no="40" segment_no="7" tag_type="text">heparin EL mass were signiﬁcantly associated with CAC after</text>
<text top="365" left="306" width="243" height="8" font="font0" id="p1_t26" reading_order_no="41" segment_no="7" tag_type="text">controlling for age, gender, and established risk factors, and</text>
<text top="377" left="306" width="243" height="8" font="font0" id="p1_t27" reading_order_no="42" segment_no="7" tag_type="text">after further adjustment for plasma lipids, waist circum-</text>
<text top="388" left="306" width="243" height="8" font="font0" id="p1_t28" reading_order_no="43" segment_no="7" tag_type="text">ference, and vasoactive medications (Table 4). In stratiﬁed</text>
<text top="400" left="306" width="243" height="8" font="font0" id="p1_t29" reading_order_no="44" segment_no="7" tag_type="text">analyses, the fourth EL quartile compared to the ﬁrst was</text>
<text top="411" left="306" width="243" height="8" font="font0" id="p1_t30" reading_order_no="45" segment_no="7" tag_type="text">associated with higher CAC scores for both pre-heparin EL</text>
<text top="422" left="306" width="243" height="9" font="font0" id="p1_t31" reading_order_no="46" segment_no="7" tag_type="text">mass, OR ¼ 1.82 (conﬁdence interval [CI] 1.02–3.24, p ¼ 0.043)</text>
<text top="433" left="306" width="243" height="9" font="font0" id="p1_t32" reading_order_no="47" segment_no="7" tag_type="text">and post-heparin EL mass, OR ¼ 7.63 (CI 2.44–23.9, p , 0.001)</text>
<text top="445" left="306" width="243" height="9" font="font0" id="p1_t33" reading_order_no="48" segment_no="7" tag_type="text">in women, while in men pre-heparin EL mass, OR ¼ 1.7 (CI</text>
<text top="456" left="306" width="243" height="9" font="font0" id="p1_t34" reading_order_no="49" segment_no="7" tag_type="text">1.0–2.9, p ¼ 0.05) but not post-heparin EL mass, OR ¼ 1.46 (CI</text>
<text top="468" left="306" width="243" height="9" font="font0" id="p1_t35" reading_order_no="50" segment_no="7" tag_type="text">0.7–3.08, p ¼ 0.31) was signiﬁcantly associated with higher</text>
<text top="480" left="306" width="48" height="8" font="font0" id="p1_t36" reading_order_no="51" segment_no="7" tag_type="text">CAC scores.</text>
<text top="504" left="306" width="50" height="10" font="font5" id="p1_t37" reading_order_no="52" segment_no="10" tag_type="title">Discussion</text>
<text top="524" left="315" width="234" height="8" font="font0" id="p1_t38" reading_order_no="53" segment_no="12" tag_type="text">We report, to our knowledge for the ﬁrst time, measure-</text>
<text top="535" left="306" width="243" height="8" font="font0" id="p1_t39" reading_order_no="54" segment_no="12" tag_type="text">ment of plasma concentrations of EL mass in routine, pre-</text>
<text top="547" left="306" width="243" height="8" font="font0" id="p1_t40" reading_order_no="55" segment_no="12" tag_type="text">heparin, and post-heparin plasma of human individuals.</text>
<text top="558" left="306" width="243" height="8" font="font0" id="p1_t41" reading_order_no="56" segment_no="12" tag_type="text">Using this newly developed sandwich ELISA, we demonstra-</text>
<text top="248" left="45" width="243" height="7" font="font6" id="p1_t42" reading_order_no="1" segment_no="3" tag_type="text">Figure 1. Pre-Heparin EL Mass Concentrations Were Determined in</text>
<text top="258" left="45" width="243" height="7" font="font7" id="p1_t43" reading_order_no="2" segment_no="3" tag_type="text">Subgroups According to the Presence of Increasing Numbers of</text>
<text top="268" left="45" width="96" height="7" font="font7" id="p1_t44" reading_order_no="3" segment_no="3" tag_type="text">Metabolic Syndrome Factors</text>
<text top="279" left="45" width="243" height="7" font="font7" id="p1_t45" reading_order_no="4" segment_no="4" tag_type="text">There was an increase in median pre-heparin EL mass as the number of</text>
<text top="287" left="45" width="243" height="7" font="font7" id="p1_t46" reading_order_no="5" segment_no="4" tag_type="text">metabolic syndrome factors increased. Median values and IQR are listed</text>
<text top="295" left="45" width="56" height="7" font="font7" id="p1_t47" reading_order_no="6" segment_no="4" tag_type="text">above each box.</text>
<text top="304" left="45" width="139" height="7" font="font7" id="p1_t48" reading_order_no="7" segment_no="6" tag_type="text">DOI: 10.1371/journal.pmed.0030022.g001</text>
<text top="220" left="306" width="243" height="7" font="font6" id="p1_t49" reading_order_no="29" segment_no="1" tag_type="text">Figure 2. Coronary Artery Calcification Scores Were Compared across</text>
<text top="230" left="306" width="199" height="7" font="font7" id="p1_t50" reading_order_no="30" segment_no="1" tag_type="text">Quartiles of Pre-Heparin EL Mass in Both Men and Women</text>
<text top="241" left="306" width="243" height="7" font="font7" id="p1_t51" reading_order_no="31" segment_no="2" tag_type="text">The box represents the 25th to 75th percentile, and the line represents</text>
<text top="250" left="306" width="243" height="7" font="font7" id="p1_t52" reading_order_no="32" segment_no="2" tag_type="text">the median CAC score within a given pre-heparin EL mass quartile. The</text>
<text top="258" left="306" width="243" height="7" font="font7" id="p1_t53" reading_order_no="33" segment_no="2" tag_type="text">whiskers represent the fifth and 95th percentiles. The diamonds are</text>
<text top="267" left="306" width="243" height="7" font="font7" id="p1_t54" reading_order_no="34" segment_no="2" tag_type="text">outliers above the 95th percentile. There was an increase in CAC scores</text>
<text top="275" left="306" width="73" height="7" font="font7" id="p1_t55" reading_order_no="35" segment_no="2" tag_type="text">as EL mass increased.</text>
<text top="284" left="306" width="139" height="7" font="font7" id="p1_t56" reading_order_no="36" segment_no="5" tag_type="text">DOI: 10.1371/journal.pmed.0030022.g002</text>
<text top="598" left="45" width="374" height="8" font="font8" id="p1_t57" reading_order_no="57" segment_no="14" tag_type="title">Table 4. Multivariable Association of Plasma EL Concentrations with Coronary Artery Calcification</text>
<text top="621" left="45" width="33" height="7" font="font6" id="p1_t58" reading_order_no="58" segment_no="15" tag_type="table">Variables</text>
<text top="621" left="112" width="78" height="7" font="font6" id="p1_t59" reading_order_no="59" segment_no="15" tag_type="table">Total: OR (CI) p -Value</text>
<text top="621" left="259" width="76" height="7" font="font6" id="p1_t60" reading_order_no="60" segment_no="15" tag_type="table">Men: OR (CI) p -Value</text>
<text top="621" left="404" width="87" height="7" font="font6" id="p1_t61" reading_order_no="61" segment_no="15" tag_type="table">Women: OR (CI) p -Value</text>
<text top="635" left="112" width="49" height="8" font="font6" id="p1_t62" reading_order_no="62" segment_no="15" tag_type="table">Pre ( n ¼ 841)</text>
<text top="635" left="184" width="53" height="8" font="font6" id="p1_t63" reading_order_no="63" segment_no="15" tag_type="table">Post ( n ¼ 366)</text>
<text top="635" left="259" width="49" height="8" font="font6" id="p1_t64" reading_order_no="64" segment_no="15" tag_type="table">Pre ( n ¼ 459)</text>
<text top="635" left="334" width="53" height="8" font="font6" id="p1_t65" reading_order_no="65" segment_no="15" tag_type="table">Post ( n ¼ 209)</text>
<text top="635" left="404" width="49" height="8" font="font6" id="p1_t66" reading_order_no="66" segment_no="15" tag_type="table">Pre ( n ¼ 382)</text>
<text top="635" left="475" width="53" height="8" font="font6" id="p1_t67" reading_order_no="67" segment_no="15" tag_type="table">Post ( n ¼ 157)</text>
<text top="657" left="45" width="36" height="6" font="font12" id="p1_t68" reading_order_no="68" segment_no="15" tag_type="table">Age, gender</text>
<text top="657" left="112" width="437" height="6" font="font12" id="p1_t69" reading_order_no="69" segment_no="15" tag_type="table">2.57 (1.8–3.68) , 0.001 3.44 (1.98–5.98) , 0.001 2.44 (1.48–4.01) , 0.001 1.71 (0.85–3.46) 0.132 3.0 (1.77–5.08) , 0.001 10.42 (3.97–27.4) , 0.001</text>
<text top="666" left="45" width="47" height="6" font="font12" id="p1_t70" reading_order_no="70" segment_no="15" tag_type="table">Age, gender, RF</text>
<text top="666" left="112" width="64" height="6" font="font12" id="p1_t71" reading_order_no="71" segment_no="15" tag_type="table">1.75 (1.19–2.56) 0.005</text>
<text top="666" left="184" width="64" height="6" font="font12" id="p1_t72" reading_order_no="72" segment_no="15" tag_type="table">2.53 (1.14–4.54) 0.002</text>
<text top="666" left="259" width="61" height="6" font="font12" id="p1_t73" reading_order_no="73" segment_no="15" tag_type="table">1.74 (1.03–2.96) 0.04</text>
<text top="666" left="334" width="61" height="6" font="font12" id="p1_t74" reading_order_no="74" segment_no="15" tag_type="table">1.47 (0.7–3.08) 0.312</text>
<text top="666" left="404" width="64" height="6" font="font12" id="p1_t75" reading_order_no="75" segment_no="15" tag_type="table">1.89 (1.07–3.36) 0.029</text>
<text top="666" left="479" width="64" height="6" font="font12" id="p1_t76" reading_order_no="76" segment_no="15" tag_type="table">5.31 (1.85–15.3) 0.002</text>
<text top="675" left="45" width="128" height="6" font="font12" id="p1_t77" reading_order_no="77" segment_no="15" tag_type="table">Age, gender, RF, BMI 1.67 (1.13–2.46) 0.01</text>
<text top="675" left="184" width="64" height="6" font="font12" id="p1_t78" reading_order_no="78" segment_no="15" tag_type="table">2.42 (1.34–4.37) 0.003</text>
<text top="675" left="259" width="50" height="6" font="font12" id="p1_t79" reading_order_no="79" segment_no="15" tag_type="table">1.7 (1.0–2.9) 0.05</text>
<text top="675" left="334" width="61" height="6" font="font12" id="p1_t80" reading_order_no="80" segment_no="15" tag_type="table">1.46 (0.7–3.08) 0.312</text>
<text top="675" left="404" width="66" height="6" font="font12" id="p1_t81" reading_order_no="81" segment_no="15" tag_type="table">1.82 (1.02-–3.24) 0.043</text>
<text top="675" left="479" width="70" height="6" font="font12" id="p1_t82" reading_order_no="82" segment_no="15" tag_type="table">7.63 (2.44–23.9) , 0.001</text>
<text top="700" left="45" width="189" height="5" font="font14" id="p1_t83" reading_order_no="83" segment_no="16" tag_type="text">The ORs are the result of a comparison between the lowest EL quartile and the highest.</text>
<text top="707" left="45" width="504" height="5" font="font14" id="p1_t84" reading_order_no="84" segment_no="17" tag_type="text">RF, risk factors: Total cholesterol, HDL-C, triglycerides, hypertension, smoking, exercise, and ethanol, glucose, waist circumference, and medication (niacin, fibrates, beta-blockers, statins, angiotensin-converting enzyme inhibitors, aspirin, and</text>
<text top="714" left="45" width="113" height="5" font="font14" id="p1_t85" reading_order_no="85" segment_no="17" tag_type="text">hormone replacement therapy [in women, n ¼ 115]).</text>
<text top="721" left="45" width="86" height="5" font="font14" id="p1_t86" reading_order_no="86" segment_no="18" tag_type="text">DOI: 10.1371/journal.pmed.0030022.t004</text>
<text top="742" left="69" width="133" height="7" font="font7" id="p1_t87" reading_order_no="87" segment_no="19" tag_type="text">PLoS Medicine | www.plosmedicine.org</text>
<text top="742" left="411" width="138" height="7" font="font7" id="p1_t88" reading_order_no="89" segment_no="20" tag_type="text">February 2006 | Volume 3 | Issue 2 | e22</text>
<text top="742" left="289" width="16" height="7" font="font7" id="p1_t89" reading_order_no="88" segment_no="21" tag_type="text">0249</text>
<text top="26" left="454" width="95" height="7" font="font7" id="p1_t90" reading_order_no="0" segment_no="0" tag_type="title">EL and Metabolic Syndrome</text>
</page>
</pdf2xml>
